Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZM-32, a human antigen R (HuR) inhibitor, effectively downregulates the expression of VEGF-A and MMP9, thereby suppressing angiogenesis in breast cancer tumors. It exhibits broad-spectrum antiproliferative effects across various cancer cell lines and demonstrates antitumor efficacy against MDA-MB-231 in mouse models.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | ZM-32, a human antigen R (HuR) inhibitor, effectively downregulates the expression of VEGF-A and MMP9, thereby suppressing angiogenesis in breast cancer tumors. It exhibits broad-spectrum antiproliferative effects across various cancer cell lines and demonstrates antitumor efficacy against MDA-MB-231 in mouse models. |
Molecular Weight | 387.56 |
Formula | C24H37NO3 |
Cas No. | 2667585-44-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.